NDC 68788-8665-06 - Telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8665
- Requested NDC
- 68788-8665-06
- Package NDCs from labels
- 68788-8665-3, 68788-8665-6, 68788-8665-9, 68788-8665-06
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-09-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Telmisartan - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2026-09-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8665-3 | Telmisartan | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 68788-8665-6 | Telmisartan | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 68788-8665-9 | Telmisartan | 90 in 1 BOTTLE | TABLET | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8665 | TELMISARTAN TABLET [PREFERRED PHARMACEUTICALS INC.] | 1 | Current NDC, 3 package rows | 20240531_d45da80a-58c3-4461-adf6-a85531c09eb8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8665-3 | EA - Each | 68788-8665 | 5150b063-8347-4b10-8282-50ae1239b316 | 1 | 2024-07-12 |
| 68788-8665-6 | EA - Each | 68788-8665 | c48d295f-11b8-4e5f-94af-25fcb0b7b834 | 1 | 2024-07-12 |
| 68788-8665-9 | EA - Each | 68788-8665 | 106ce74e-2b4f-4fb8-a360-c6ecf6a3e470 | 1 | 2024-07-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| telmisartan | TELMISARTAN | PD-Rx Pharmaceuticals, Inc. | 56a72ddf-c2a2-45ce-91b1-1fcfbff52c10 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | 282755 U5SYW473RQ |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Limited | 15b438b4-4874-43f4-a50a-4e6f3e5530ac | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Amlodipine | TELMISARTAN AND AMLODIPINE | Alembic Pharmaceuticals Inc. | 14f9b590-4c43-439c-a647-9fc2b0fd4d7f | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Aurobindo Pharma Limited | 681dfb5c-fc5c-427e-81f6-4b4e934978a2 | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | dd2b0604-f887-40d9-9109-dafcc9987e4e | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | f6da5155-9c26-46bb-bc0f-ece4ea21405f | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | 282755 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | d45da80a-58c3-4461-adf6-a85531c09eb8 | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | ANDA207882 68788-8665-9 68788-8665-6 68788-8665-3 68788-8665 68788866506 205304 4f5c9ed6-258b-47a8-b66e-a7a6a91bc038 d45da80a-58c3-4461-adf6-a85531c09eb8 U5SYW473RQ |
| telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | 963e9245-ec7a-4bf6-9fc0-80f54e3657f0 | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | 205304 U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | AvKARE | 1b303136-dccd-178b-e063-6394a90a35f8 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan | TELMISARTAN | REMEDYREPACK INC. | 57da6ef2-2e86-4e4d-90df-73a2a8cf97f6 | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | ANDA207882 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | REMEDYREPACK INC. | 91215664-6e19-4e04-9ae7-ab5664799426 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Redpharm Drug | 5743c58e-deab-ac93-e063-6294a90ac1eb | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 282755 U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | e80f232c-c1c4-4524-a0a5-d23ee0d1f3b7 | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Telmisartan and Hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 5b476740-e3f0-4f68-b07c-cd9eb2fa27ca | 2026-07-22 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| WIDAPLIK | TELMISARTAN, AMLODIPINE AND INDAPAMIDE | Azurity Pharmaceuticals, Inc. | a30ff81d-420b-40ea-83d8-670260a93fff | 2026-07-03 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| telmisartan | TELMISARTAN | REMEDYREPACK INC. | 09d31eee-cd22-4918-a889-3eb4d2969525 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Alembic Pharmaceuticals Limited | 4be6575f-ea8d-4cd8-a49d-3d1c93f2621a | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Alembic Pharmaceuticals Inc. | c62d424c-7630-413c-be2c-3932831c3f1d | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 205304 282755 205305 U5SYW473RQ |
| Telmisartan | TELMISARTAN | Bryant Ranch Prepack | 830741dd-3f3c-4f8e-88c6-dc112166f477 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | ANDA207882 205305 U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.